Literature DB >> 29110039

[Endoscopic and surgical treatment of early gastric and esophageal carcinoma].

T Haist1, M Knabe2, A May2, D Lorenz3.   

Abstract

BACKGROUND: The treatment of early gastric (EGC) and esophageal carcinomas (EEC) is an interdisciplinary challenge. The risk of lymph node metastasis (LNM) is the crucial point in choosing the correct treatment option.
OBJECTIVE: This article gives an overview of the current treatment options and provides help in choosing the correct therapy.
METHOD: Current concepts and therapy algorithms are presented on the basis of a literature review and data from our own center.
RESULTS: Endoscopic submucosal dissection (ESD) is recommended for mucosal gastric cancer with good or moderate differentiation (G1,2) without macroscopic ulceration, in elevated type lesions smaller than 2 cm in size or depressed lesions smaller than 1 cm in size. In additional chromoendoscopy should be carried out. The extent of surgical resection is defined by the location of the tumor. A safety margin of at least 3 cm should be applied in distal gastric resections whereas the first line goal in gastrectomy is to achieve an R0 resection. In cN0 tumors a D1 lymphadenectomy (LA) seems to be sufficient. Minimally invasive techniques currently show promising results especially for a subtotal resection. The treatment strategy in EEC differs depending on the tumor entity. Mucosal squamous cell carcinoma with high risk factors (L1,V1) and all cN0 submucosal tumors without the detection of LNM should be referred to primary surgical resection. Early stage cN+ squamous cell carcinomas should be preoperatively treated with chemoradiotherapy. Adenocarcinoma with infiltration of the deeper submucosa (sm2,3) and high-risk sm1 tumors require surgical treatment. The standard operating procedure for EEC is an Ivor Lewis esophagectomy with 2‑field LA preferably performed as a hybrid or by a completely minimally invasive procedure. The procedure of choice in endoscopic resection of EEC is resection with the suck and cut technique.

Entities:  

Keywords:  Adenocarcinoma; Endoscopic therapy; Indications; Squamous cell carcinoma; Surgical treatment

Mesh:

Year:  2017        PMID: 29110039     DOI: 10.1007/s00104-017-0543-8

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  37 in total

1.  Prognostic relevance of skip metastases in esophageal cancer.

Authors:  Klaus L Prenzel; Elfriede Bollschweiler; Wolfgang Schröder; Stefan P Mönig; Uta Drebber; Daniel Vallboehmer; Arnulf H Hölscher
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

2.  Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer (Br J Surg 2014; 101: 23-31).

Authors:  C J H van de Velde
Journal:  Br J Surg       Date:  2014-01       Impact factor: 6.939

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative.

Authors:  Malcolm H Squires; David A Kooby; George A Poultsides; Timothy M Pawlik; Sharon M Weber; Carl R Schmidt; Konstantinos I Votanopoulos; Ryan C Fields; Aslam Ejaz; Alexandra W Acher; David J Worhunsky; Neil Saunders; Edward A Levine; Linda X Jin; Clifford S Cho; Mark Bloomston; Emily R Winslow; Maria C Russell; Ken Cardona; Charles A Staley; Shishir K Maithel
Journal:  Ann Surg Oncol       Date:  2014-10-15       Impact factor: 5.344

5.  Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions.

Authors:  H Inoue; K Takeshita; H Hori; Y Muraoka; H Yoneshima; M Endo
Journal:  Gastrointest Endosc       Date:  1993 Jan-Feb       Impact factor: 9.427

6.  The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns.

Authors:  Hendrik Manner; Oliver Pech; Yvonne Heldmann; Andrea May; Michael Pauthner; Dietmar Lorenz; Annette Fisseler-Eckhoff; Manfred Stolte; Michael Vieth; Christian Ell
Journal:  Surg Endosc       Date:  2014-10-08       Impact factor: 4.584

7.  Limited resection for early adenocarcinoma in Barrett's esophagus.

Authors:  H J Stein; M Feith; J Mueller; M Werner; J R Siewert
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

8.  The distance of proximal resection margin dose not significantly influence on the prognosis of gastric cancer patients after curative resection.

Authors:  Min Gyu Kim; Ju-Hee Lee; Tae Kyung Ha; Sung Joon Kwon
Journal:  Ann Surg Treat Res       Date:  2014-10-24       Impact factor: 1.859

9.  Magnifying endoscopy with narrow-band imaging is more accurate for determination of horizontal extent of early gastric cancers than chromoendoscopy.

Authors:  Itsuko Asada-Hirayama; Shinya Kodashima; Yoshiki Sakaguchi; Satoshi Ono; Keiko Niimi; Satoshi Mochizuki; Yosuke Tsuji; Chihiro Minatsuki; Satoki Shichijo; Keisuke Matsuzaka; Tetsuo Ushiku; Masashi Fukayama; Nobutake Yamamichi; Mitsuhiro Fujishiro; Kazuhiko Koike
Journal:  Endosc Int Open       Date:  2016-06

10.  A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia.

Authors:  Grischa Terheggen; Eva Maria Horn; Michael Vieth; Helmut Gabbert; Markus Enderle; Alexander Neugebauer; Brigitte Schumacher; Horst Neuhaus
Journal:  Gut       Date:  2016-01-22       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.